Dr. Dai Wing Chiu - General Surgery
Specialist in General Surgery
Highlights
- MCHK RegisteredVerified
- Specialist in General SurgeryBachelor of Medicine and Bachelor of Surgery (MBBS) · The College of Surgeons of Hong Kong · Medical degree 2002
- InsuranceBeing compiled｜See details
About
Dr. Dai Wing Chiu is a registered General Surgery specialist in Hong Kong.
Education
Specialist in General Surgery
- Bachelor of Medicine and Bachelor of Surgery (MBBS)Bachelor of Medicine and Bachelor of Surgery (MBBS)2002
Hong Kong Academy of Medicine fellowships
- FCSHKFellow, The College of Surgeons of Hong Kong
Source: Hong Kong Academy of Medicine Fellows Register, checked 12 Sep 2026
Insurance
Insurance plans being compiled
We're collecting insurance plan data per clinic. For confirmation, contact the clinic directly.
Are you Dr. Dai Wing Chiu? Claim page and update insurance →
FAQ
Is Dr. Dai Wing Chiu any good?
Dr. Dai Wing Chiu is a registered General Surgery specialist in Hong Kong. Qualifications and registration come from the Hong Kong Medical Council. ok.med does not rate or rank doctors.
What does Dr. Dai Wing Chiu do?
Dr. Dai Wing Chiu practises in General Surgery.
Are you Dr. Dai Wing Chiu? Claim this page to update and manage.
ClaimResearch and publications
31 papers · 12 most recent shown
Filter by paper topic
Topics come from medical classifications on these PubMed papers, not from the doctor's listed services.
- Survival impact of conversion therapy for Barcelona Clinic Liver Cancer (BCLC) stage B and C hepatocellular carcinoma-a propensity score matching analysis.Hepatobiliary surgery and nutrition · 2025
- Epidemiological changes in the pattern of children's traumatic injuries at Hong Kong emergency departments during the COVID-19 pandemic: a retrospective, single-institutional, serial and comparative study.Pediatric surgery international · 2024
- Sequential transarterial chemoembolisation and stereotactic body radiotherapy followed by immunotherapy as conversion therapy for patients with locally advanced, unresectable hepatocellular carcinoma (START-FIT): a single-arm, phase 2 trial.The lancet. Gastroenterology & hepatology · 2023
- High prevalence of de novo metabolic dysfunction-associated fatty liver disease after liver transplantation and the role of controlled attenuation parameter.BMC gastroenterology · 2023
- Defining the surgical management for non-colorectal liver metastases.Langenbeck's archives of surgery · 2023
- Impact of Time to Recurrence on Survival Outcome of Salvage Liver Transplantation.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2022
- Performance of Dual-tracer PET-CT for Staging Post-Liver Transplant Hepatocellular Carcinoma Recurrence.Transplantation direct · 2021
- Model for End-Stage Liver Disease With Additional Criteria to Predict Short-Term Mortality in Severe Flares of Chronic Hepatitis B.Hepatology (Baltimore, Md.) · 2020
- Evaluation of Pancreatic Lesions With Endoscopic Ultrasound and Fine Needle Aspiration.Surgical innovation · 2020
- Better survival after stereotactic body radiation therapy following transarterial chemoembolization in nonresectable hepatocellular carcinoma: A propensity score matched analysis.Surgical oncology · 2019
- Impact of small-for-size liver grafts on medium-term and long-term graft survival in living donor liver transplantation: A meta-analysis.World journal of gastroenterology · 2019
- Validated nomogram for the prediction of disease-free survival after hepatectomy for hepatocellular carcinoma within the Milan criteria: individualizing a surveillance strategy.Surgery today · 2019
Publication data comes from PubMed / Europe PMC and is matched automatically by name and affiliation. Every entry links to the source.
For reference only. Not medical advice. Read full disclaimer